Wellxim 500 MG Tablet contains Cefuroxime 500 mg, a second-generation cephalosporin antibiotic effective against a broad spectrum of bacterial infections. It functions by inhibiting bacterial cell wall synthesis, leading to cell lysis and death, thereby treating infections caused by susceptible organisms. Wellxim is indicated for the treatment of respiratory tract infections, urinary tract infections, skin and soft tissue infections, bone and joint infections, and certain sexually transmitted infections. It is also used in the management of Lyme disease and surgical prophylaxis. The tablet is administered orally, with dosage and duration tailored according to the severity and type of infection, as well as patient-specific factors such as age and renal function. Wellxim exhibits good oral bioavailability and penetrates well into respiratory secretions and tissues. Common side effects may include gastrointestinal disturbances such as nausea, diarrhea, and abdominal discomfort, while hypersensitivity reactions, though rare, should be monitored. Caution is advised in patients with a history of penicillin or cephalosporin allergy. Renal impairment may necessitate dose adjustment. Wellxim 500 MG Tablet should be used under medical supervision to ensure appropriate use and to minimize the development of antibiotic resistance.